The University of Tokyo Edge Capital is a venture capital firm based in Tokyo, Japan, founded in 2004. It specializes in seed and early-stage investments, focusing on deep-tech sectors including healthcare and life sciences, information technology and artificial intelligence, as well as physical sciences and engineering. UTEC collaborates with academic institutions, notably The University of Tokyo, to identify and support innovative startups. With over $500 million in assets under management, the firm has invested in more than 100 companies across Japan, the United States, Singapore, India, and Europe, achieving a notable track record that includes 13 initial public offerings and 12 successful mergers and acquisitions.
Piece is a platform for investing in rented properties, offering monthly rental income and long-term appreciation for everyone.
Aerem
Series A in 2025
Aerem is a Mumbai-based FinTech platform dedicated to promoting clean energy solutions for businesses and commercial enterprises. By facilitating the adoption of rooftop solar systems, Aerem enables organizations to significantly reduce electricity costs by up to 70%. The company utilizes a comprehensive installer network and offers financing options through its in-house non-banking financial company or partner banks, making it easier for businesses, particularly micro, small, and medium enterprises, to transition to solar energy. Aerem’s mission is to democratize access to clean energy and contribute to a sustainable future, achieving a positive impact on the environment, society, and economy through its innovative services. With its growing presence across India, Aerem is positioned to lead the charge in solar energy adoption.
TriOrb
Series B in 2025
Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.
RegCell
Seed Round in 2025
RegCell is focused on developing innovative therapies for autoimmune diseases and cancer by enhancing or regulating the immune system. The company specializes in creating cell therapies that aim to address significant unmet medical needs. By returning regulatory T cells to the patient and activating them in vitro, RegCell seeks to provide effective treatment options for individuals suffering from these challenging conditions. Through its novel approach, the company aims to improve patient outcomes and address the complexities associated with autoimmune disorders and cancer.
issin
Venture Round in 2025
Developer of healthcare devices intended for weight management. The company's product is a bath mat that automatically tracks the weight of all the members of the family, records daily weight changes and provides data in the application synced with the mat and is equipped with various modes which fulfill the lifelong weight management needs of various stages of life including babies to elder people, enabling users to monitor their weight and body mass index for lifestyle improvement.
Eureka Robotics
Series A in 2024
Eureka Robotics is a technology company that specializes in developing robotic systems and software aimed at automating tasks that require high accuracy and agility. Drawing on research from prestigious institutions such as NTU Singapore and MIT, the company provides solutions that enhance productivity, reduce costs, and improve safety in various manufacturing processes. Its offerings are applicable across a range of industries, including healthcare, telecommunications, automotive, photonics, electronics, and aerospace. With offices located in Singapore, France, and Vietnam, and distribution partners in China, Japan, and the United States, Eureka Robotics is committed to enabling clients to efficiently manage complex tasks such as precision handling, assembly, inspection, and drilling, allowing human workers to focus more on creative activities rather than routine decisions.
Liminal
Venture Round in 2024
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
estie
Series B in 2024
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.
SUN METALON
Series A in 2024
SUN METALON specializes in innovative technology aimed at decarbonizing metal manufacturing through processes such as recycling, refining, and forming. The company also manufactures three-dimensional printers designed for local production of metal parts, allowing for on-site fabrication. This approach enables clients to efficiently create metal products in various environments while reducing costs. By combining advanced manufacturing techniques with a focus on sustainability, SUN METALON aims to transform the metal industry and promote more environmentally friendly practices.
TriOrb
Series B in 2024
Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.
Quanmatic
Series A in 2024
Quanmatic is an information and technology company focused on developing algorithms and solutions to connect quantum technologies with real-world applications. The company has created an experiential learning platform that features tutorial content and demonstration applications designed for combinatorial optimization problems. This platform allows users to input mathematical data and run quantum annealing machines directly from a web browser, enabling them to tackle large-scale challenges effectively. By bridging the gap between advanced quantum technology and practical problem-solving, Quanmatic aims to enhance understanding and utilization of quantum computing in various fields.
Celaid Therapeutics
Series A in 2024
Celaid Therapeutics focuses on the development and commercialization of regenerative medicine products that utilize human hematopoietic stem cells. The company specializes in cell therapy, leveraging advanced techniques for the expansion of these stem cells to create innovative medical solutions. In addition to its therapeutic offerings, Celaid Therapeutics also supports research and discovery by providing essential media reagents. This approach enables medical professionals to enhance hematopoietic stem cell transplantation and integrate gene-editing technology into their treatments, thereby advancing the field of regenerative medicine.
Red Arrow Therapeutics
Seed Round in 2024
Developer of a healthcare technology designed to replace the traditional way of treating cancer treatment. The company aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity, helping the healthcare sector to overcome systemic toxicity and exhibiting strong anti-tumor efficacy in various tumor models both as monotherapy and in combination with immune checkpoint inhibitors.
SWAT Mobility
Venture Round in 2024
SWAT Mobility specializes in vehicle-routing technology aimed at addressing complex transportation challenges faced by companies, transport operators, and government agencies globally. The company's innovative solutions utilize advanced artificial intelligence algorithms to optimize route planning and pooling, enhancing transport efficiency while accommodating multiple waypoints. By offering high-capacity vehicle pooling services that are both on-demand and dynamically routed, SWAT Mobility has demonstrated success in reducing transportation costs, improving urban connectivity, and alleviating traffic congestion. Their technology is designed to meet current logistics needs and is well-positioned for future advancements, including the integration of autonomous vehicles.
X Mile
Series B in 2024
X Mile is a human resources platform focused on connecting logistics companies with drivers. It develops a software-as-a-service (SaaS) solution aimed at addressing workforce challenges, such as labor shortages and low productivity. The platform operates by providing recruitment services across various sectors, including logistics, automobile maintenance, and construction. By supporting agents in these fields, X Mile enhances operational efficiency and helps increase sales for non-desk businesses, facilitating better management and workforce solutions.
TriOrb
Series A in 2023
Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.
Alumnote
Seed Round in 2023
Alumnote develops an alumni association management software that enables educational institutions to manage their alumni networks online. The company focuses on enhancing fundraising efforts and activating alumni communities by providing digital tools that facilitate loyalty building and donor engagement. Alumnote supports schools in executing donation acquisition strategies, constructing graduate databases, and improving community management efficiency. Through its services, Alumnote aims to promote a culture of giving among graduates, ultimately accelerating the flow of funds to support educational initiatives.
Oxford Quantum Circuits
Series B in 2023
Oxford Quantum Circuits specializes in quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company has developed a fully functional quantum computer that integrates control systems, hardware, and software, enabling customers to streamline operations and explore innovative solutions. Their unique superconducting circuits are designed to maintain high qubit quality and control, which is essential for achieving commercially viable processing power. By leveraging this advanced technology, Oxford Quantum Circuits supports a range of applications, from pioneering new battery technologies to facilitating life-changing discoveries in medicine.
Obviously AI
Venture Round in 2023
Obviously AI, Inc. is a company that specializes in developing cloud-based data science solutions. Founded in 2018 and based in Berkeley, California, the firm provides a platform that allows users to conduct complex predictions and analytics by posing questions in natural language, without the need for coding. Its technology employs data science and machine learning to interpret these questions, identify relevant data, and execute machine learning algorithms to generate predictions. The platform is designed to help businesses understand customer behavior and tailor marketing strategies by analyzing existing structured data. Ultimately, Obviously AI aims to empower organizations to leverage artificial intelligence effectively and efficiently.
RICOS
Series A in 2023
RICOS is a technology company focused on enhancing manufacturing processes through the integration of artificial intelligence, simulation, and high-performance computing. The company has developed an AI algorithm known as IsoGCN, specifically designed to utilize simulation data for more efficient and interactive design and evaluation. RICOS offers a browser-based platform that merges Computer-Aided Engineering with advanced computational techniques, facilitating more accurate calculations and quicker research outcomes. The company's mission is to create a future where scientific computing technologies are seamlessly applied in manufacturing environments, allowing for immediate realization of innovative ideas and improvements in production efficiency.
United Immunity
Venture Round in 2023
United Immunity, Co., Ltd., established on November 27, 2017, and headquartered in Tsu, Japan, specializes in the research, development, manufacture, and sales of pharmaceuticals, with a primary focus on cancer immunotherapy. The company is known for its innovative use of nanoparticles and lipid nanoparticles to target myeloid cells, facilitating the delivery of therapeutic agents directly to macrophages and dendritic cells. This technology supports the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases. United Immunity aims to advance therapeutic options and improve patient outcomes through its specialized research and development efforts.
Peach Cars
Seed Round in 2023
Peach Cars operates a used car marketplace designed to facilitate transparent and efficient transactions for buying and selling vehicles. The platform features a user-friendly interface that allows users to navigate through verified used cars while ensuring a hassle-free experience. Additionally, Peach Cars offers services related to car maintenance and secure payment options, leveraging Internet of Things (IoT) technology and machine learning to enhance the trading process. This innovative approach aims to simplify vehicle transactions for customers in sub-Saharan Africa.
Cellusion
Series C in 2023
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Violet Therapeutics
Venture Round in 2023
Violet Therapeutics is a pre-clinical stage company focused on drug discovery for central nervous system (CNS) diseases. It utilizes a unique platform that employs barcoded viral tracing to identify, map, and analyze cellular connectomes at a large scale. This innovative approach allows for detailed insights into cell-cell interactions at the single-cell level, which is crucial for advancing treatments for neuroinflammation. Co-founded by Mass General Brigham Ventures and researchers from Brigham & Women’s Hospital, Violet Therapeutics is dedicated to developing novel therapeutic targets that can lead to significant breakthroughs in CNS disease treatment.
Tricog Health
Series C in 2023
Tricog Health specializes in developing advanced cardiac diagnostic tools aimed at addressing cardiovascular conditions with precision and timeliness. Utilizing medical-grade artificial intelligence, Tricog's solutions facilitate real-time reporting and analysis of electrocardiography results, enabling healthcare providers to identify cardiac issues quickly and accurately. The company focuses on bridging gaps in cardiac care infrastructure, expertise, and efficiency, ensuring that patients receive prompt diagnoses and timely interventions. Tricog is dedicated to enhancing cardiac care accessibility by providing virtual diagnostic tools and services, thereby supporting healthcare professionals in delivering reliable and consistent patient care.
Liminal
Series A in 2023
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
X Mile
Series A in 2023
X Mile is a human resources platform focused on connecting logistics companies with drivers. It develops a software-as-a-service (SaaS) solution aimed at addressing workforce challenges, such as labor shortages and low productivity. The platform operates by providing recruitment services across various sectors, including logistics, automobile maintenance, and construction. By supporting agents in these fields, X Mile enhances operational efficiency and helps increase sales for non-desk businesses, facilitating better management and workforce solutions.
HashPort
Series C in 2023
HashPort, founded in 2018, assists emerging web3 businesses by providing development support and financing through Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products, including digital wallets and non-fungible token (NFT) platforms. In 2020, it launched HashPalette, a subsidiary that achieved a milestone by conducting Japan's first approved IEO and developing a dedicated blockchain for NFTs, along with operating one of the country’s largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round led by six underwriters. The firm also offers consulting services aimed at helping crypto-asset exchange companies explore and implement blockchain technologies, further facilitating the digitalization of assets.
PaylessGate
Venture Round in 2022
PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.
SUN METALON
Venture Round in 2022
SUN METALON specializes in innovative technology aimed at decarbonizing metal manufacturing through processes such as recycling, refining, and forming. The company also manufactures three-dimensional printers designed for local production of metal parts, allowing for on-site fabrication. This approach enables clients to efficiently create metal products in various environments while reducing costs. By combining advanced manufacturing techniques with a focus on sustainability, SUN METALON aims to transform the metal industry and promote more environmentally friendly practices.
Obniz
Series B in 2022
Obniz is a technology company that specializes in Internet of Things (IoT) services, offering a cloud-based system for real-time and bi-directional access to physical hardware. This platform enables users to remotely control various devices, including sensors, actuators, and machines, through the cloud. Obniz provides solutions for location information acquisition and environmental management, allowing clients to seamlessly connect their devices to the cloud and manage them effectively.
Oxford Quantum Circuits
Series A in 2022
Oxford Quantum Circuits specializes in quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company has developed a fully functional quantum computer that integrates control systems, hardware, and software, enabling customers to streamline operations and explore innovative solutions. Their unique superconducting circuits are designed to maintain high qubit quality and control, which is essential for achieving commercially viable processing power. By leveraging this advanced technology, Oxford Quantum Circuits supports a range of applications, from pioneering new battery technologies to facilitating life-changing discoveries in medicine.
Wassha
Series C in 2022
Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.
Frontier Field
Series B in 2022
Frontier Field is a venture company that brings the medical and healthcare fields together with the power of IT. It also engaged in the planning, development, sales, and maintenance of the nibyo mobile smartphone exclusively for medical institutions.
OriCiro Genomics
Series B in 2022
OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.
Eureka Robotics
Seed Round in 2022
Eureka Robotics is a technology company that specializes in developing robotic systems and software aimed at automating tasks that require high accuracy and agility. Drawing on research from prestigious institutions such as NTU Singapore and MIT, the company provides solutions that enhance productivity, reduce costs, and improve safety in various manufacturing processes. Its offerings are applicable across a range of industries, including healthcare, telecommunications, automotive, photonics, electronics, and aerospace. With offices located in Singapore, France, and Vietnam, and distribution partners in China, Japan, and the United States, Eureka Robotics is committed to enabling clients to efficiently manage complex tasks such as precision handling, assembly, inspection, and drilling, allowing human workers to focus more on creative activities rather than routine decisions.
Liminal
Series A in 2022
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.
BUGWORKS Research
Series B in 2022
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
Eplane
Seed Round in 2022
Eplane builds and develops electric air transportation systems.
The ePlane Company
Seed Round in 2022
ePlane aims to tackle urban road traffic congestion by introducing innovative flying solutions. Their flagship product aims to provide a safe, sustainable, and affordable flying experience, contributing to a future of urban mobility that is efficient and eco-friendly.
Cellusion
Venture Round in 2022
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.
Forest
Seed Round in 2021
Forest Co., Ltd. is an e-commerce aggregator focused on identifying and promoting sustainable, high-quality products that embody the essence of Japan. The company employs a technology-driven platform to acquire and support third-party brands, leveraging a specialized team that tailors marketing strategies to the unique attributes of each brand. By utilizing a deep understanding of digital algorithms, Forest optimizes advertising efforts to facilitate growth and enhance the global market presence of its partners.
RICOS
Series A in 2021
RICOS is a technology company focused on enhancing manufacturing processes through the integration of artificial intelligence, simulation, and high-performance computing. The company has developed an AI algorithm known as IsoGCN, specifically designed to utilize simulation data for more efficient and interactive design and evaluation. RICOS offers a browser-based platform that merges Computer-Aided Engineering with advanced computational techniques, facilitating more accurate calculations and quicker research outcomes. The company's mission is to create a future where scientific computing technologies are seamlessly applied in manufacturing environments, allowing for immediate realization of innovative ideas and improvements in production efficiency.
Charco Neurotech
Seed Round in 2021
Charco Neurotech is a medical technology company focused on developing non-invasive wearable devices aimed at improving the quality of life for individuals with Parkinson's disease. The company's primary product is designed to modulate sensory dysfunction, which assists users in enhancing their movement speed. By providing a solution that allows people with Parkinson's to maintain a more normal lifestyle, Charco Neurotech addresses significant challenges faced by this population, ultimately contributing to better overall health and well-being.
ALGO ARTIS
Series A in 2021
ALGO ARTIS is a software company that specializes in optimizing various aspects of operational management, including plant operations, tanking, ship allocation planning, and logistics. The company employs algorithmic methods and artificial intelligence technology to enhance efficiency in social infrastructure management. By focusing on the selection of appropriate technologies and processes, ALGO ARTIS enables businesses to streamline operations, thereby improving overall performance and effectiveness.
Capex
Venture Round in 2021
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
OriCiro Genomics
Series B in 2021
OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.
VividQ
Seed Round in 2021
VividQ Limited is a software company specializing in the development of a framework that enables the generation, compression, and transmission of 3D holographic images and video. The company offers several key products, including VividQ Capture, which standardizes 3D data for holographic display, and VividQ Squeeze, a compression solution for point cloud data storage. Additionally, VividQ Core facilitates multi-user interactions with holograms, while VividQ View allows developers to integrate various spatial light modulators into their systems. The company's technology is utilized across various sectors, including consumer electronics, augmented and virtual reality, automotive displays, and immersive simulations. Founded in 2015 and based in Cambridge, United Kingdom, VividQ collaborates with leading original equipment manufacturers to integrate its advanced software and hardware solutions into next-generation consumer devices, aiming to create a seamless blend of real and virtual experiences.
PaylessGate
Seed Round in 2021
PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.
EditForce
Series A in 2021
EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. The company specializes in genome editing alternatives and offers advanced tools for RNA molecule editing, utilizing pentatricopeptide repeat (PPR) protein engineering technologies. EditForce's innovations focus on manipulating nucleic acids, specifically DNA and RNA, to facilitate research and development in various fields, including biological research, medicine, agriculture, and bio-production. Their technology allows for precise targeting of base sequences in nucleic acids, enabling significant advancements in drug development and seed research.
Startbahn
Series B in 2021
Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.
Obviously AI
Seed Round in 2021
Obviously AI, Inc. is a company that specializes in developing cloud-based data science solutions. Founded in 2018 and based in Berkeley, California, the firm provides a platform that allows users to conduct complex predictions and analytics by posing questions in natural language, without the need for coding. Its technology employs data science and machine learning to interpret these questions, identify relevant data, and execute machine learning algorithms to generate predictions. The platform is designed to help businesses understand customer behavior and tailor marketing strategies by analyzing existing structured data. Ultimately, Obviously AI aims to empower organizations to leverage artificial intelligence effectively and efficiently.
DataFluct
Series A in 2021
DataFluct Inc., founded in 2019 and headquartered in Chiyoda City, Japan, offers a free satellite image search service that allows users to access satellite imagery. As a subsidiary of Factorium Inc., DataFluct specializes in data management and machine learning services aimed at addressing corporate and social challenges through data science. The company focuses on developing sustainable algorithms that optimize solutions while considering environmental, social, customer, and economic values. Additionally, DataFluct operates as a data science startup studio, utilizing full-stack technology for data collection, storage, analysis, and application. This enables businesses to predict future trends and derive value from previously underutilized data, ultimately fostering innovation and growth.
ImmunoScape
Venture Round in 2021
ImmunoScape is a company specializing in immunomics, focusing on immune profiling and the characterization of the human immune response with high precision. Its Deep Immunomics platform integrates advanced technologies such as mass cytometry, single cell sequencing, and proprietary computational bioinformatics to deliver detailed immune profiling information. This platform is particularly valuable in therapeutic areas like oncology and infectious diseases, where it aids in understanding the safety and efficacy of immunotherapies and in identifying potential drug targets. Additionally, ImmunoScape offers a software suite that includes immune cell profiling technologies and antigen-specific T-cell identification, providing crucial insights for companies involved in the research and clinical development of immunotherapies.
Obniz
Series A in 2021
Obniz is a technology company that specializes in Internet of Things (IoT) services, offering a cloud-based system for real-time and bi-directional access to physical hardware. This platform enables users to remotely control various devices, including sensors, actuators, and machines, through the cloud. Obniz provides solutions for location information acquisition and environmental management, allowing clients to seamlessly connect their devices to the cloud and manage them effectively.
HashPort
Venture Round in 2021
HashPort, founded in 2018, assists emerging web3 businesses by providing development support and financing through Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products, including digital wallets and non-fungible token (NFT) platforms. In 2020, it launched HashPalette, a subsidiary that achieved a milestone by conducting Japan's first approved IEO and developing a dedicated blockchain for NFTs, along with operating one of the country’s largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round led by six underwriters. The firm also offers consulting services aimed at helping crypto-asset exchange companies explore and implement blockchain technologies, further facilitating the digitalization of assets.
SWAT Mobility
Venture Round in 2021
SWAT Mobility specializes in vehicle-routing technology aimed at addressing complex transportation challenges faced by companies, transport operators, and government agencies globally. The company's innovative solutions utilize advanced artificial intelligence algorithms to optimize route planning and pooling, enhancing transport efficiency while accommodating multiple waypoints. By offering high-capacity vehicle pooling services that are both on-demand and dynamically routed, SWAT Mobility has demonstrated success in reducing transportation costs, improving urban connectivity, and alleviating traffic congestion. Their technology is designed to meet current logistics needs and is well-positioned for future advancements, including the integration of autonomous vehicles.
Agara
Seed Round in 2021
Agara Labs, based in Bengaluru, India, is a technology company that specializes in automating customer support operations for large enterprises. Founded in 2017, Agara has developed an autonomous voice conversation agent capable of managing customer support calls without human intervention. This system processes multi-format data, including text, audio, and images, from various communication channels such as emails, chats, phone calls, and social media in real time. By generating predictions in the form of classification labels, intents, and responses, Agara's solution enhances customer experience while significantly reducing support costs. Targeting sectors such as financial services, consumer products, and retail, the company's technology allows enterprises to effectively address customer queries and feedback, simulating the capabilities of a human agent.
Metcela
Series B in 2021
Metcela Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cardiac diseases. Founded in 2016 and based in Kawasaki, Japan, Metcela specializes in fibroblast-based treatments, particularly its lead asset, MTC001. This therapy utilizes VCAM-1-positive Cardiac Fibroblasts, which are derived from the patient's own heart cells. Rather than replacing damaged cells, the therapy enhances the body's natural healing processes to repair heart tissue and restore a favorable microenvironment. Through its research and development efforts, Metcela aims to offer patients an effective and affordable alternative for treating heart failure.
Capex
Venture Round in 2020
Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.
Japan Data Science Consortium
Series B in 2020
Japan Data Science Consortium Co. is a Tokyo-based company specializing in artificial intelligence, the Internet of Things, and robotics. Founded in 2014, it offers a range of services including demand forecasting, predictive maintenance, digital transformation, optical character recognition, and image recognition. The company focuses on providing solutions tailored to the medical, education, and retail sectors, aiming to facilitate significant profit impact through comprehensive consulting. JDSC supports clients from system construction to corporate process transformation, ensuring the effective integration of AI technologies into their operations.
Epigeneron
Series B in 2020
Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs. Founded in 2015, the company specializes in creating treatments for a range of serious conditions, including cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron is recognized for its expertise in drug discovery and offers services related to the development of epigenetic and anti-microbial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to identify specific genomic interactions, which aids in the development of gene therapies aimed at treating severe immune diseases and other disorders affecting the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and related research equipment, as well as the transfer of intellectual property associated with its innovations.
BionicM
Series A in 2020
BionicM is a Tokyo-based company focused on researching, developing, and commercializing advanced mobility devices that integrate robotics with the human body. Established as a joint-stock company in 2018, BionicM specializes in high-performance robotic prosthetics, including ankle-foot and knee joints, designed to enhance mobility for individuals with disabilities. The company has been engaged in innovative technology research since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, working under the guidance of Professor Inaba. BionicM's products aim to enable users, including both handicapped and non-handicapped individuals, to perform essential daily activities such as standing, walking, and climbing stairs.
bitBiome
Series B in 2020
bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms, employing single-cell technology to enhance enzyme discovery and engineering. The company boasts the largest proprietary database of natural microbial sequences, primarily sourced from environmental collections. Through its microbial single-cell sequencing platform, bit-MAP, it provides a variety of services, including single-cell genomics, database screening, and wet lab evaluation of target sequences. Additionally, bitBiome is dedicated to developing new diagnostics and drugs by analyzing bacteria that promote human health on a cell-by-cell basis.
Tellus
Series A in 2020
Tellus is a health monitoring platform focused on enhancing eldercare quality and operational efficiency. It utilizes advanced, wireless sensor technology to monitor vital signs and activity without the need for wearables or video cameras. The platform provides real-time alerts and actionable insights related to fall detection, sleep patterns, pulse, behavior, heart rate, and breathing rate. By analyzing baseline health data, Tellus enables care facilities to respond effectively during emergencies and make informed decisions to improve the well-being of their residents.
ImmunoScape
Venture Round in 2020
ImmunoScape is a company specializing in immunomics, focusing on immune profiling and the characterization of the human immune response with high precision. Its Deep Immunomics platform integrates advanced technologies such as mass cytometry, single cell sequencing, and proprietary computational bioinformatics to deliver detailed immune profiling information. This platform is particularly valuable in therapeutic areas like oncology and infectious diseases, where it aids in understanding the safety and efficacy of immunotherapies and in identifying potential drug targets. Additionally, ImmunoScape offers a software suite that includes immune cell profiling technologies and antigen-specific T-cell identification, providing crucial insights for companies involved in the research and clinical development of immunotherapies.
estie
Seed Round in 2020
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.
TXP Medical
Series A in 2020
TXP Medical, Inc. specializes in the development and sale of patient information recording and management systems. Founded in 2017 and based in Bunkyo, Japan, the company offers a range of products including the NEXTStage ER platform, which supports medical record input and clinical research, as well as mobile applications that facilitate patient information entry through voice commands and image recognition. TXP Medical aims to enhance decision-making in the medical field by creating a comprehensive data platform for emergency outpatients, enabling hospitals to digitize emergency medical care. The company's offerings also include a self-assessment system that allows patients to input their own data, contributing to improved healthcare delivery and quality of life.
BUGWORKS Research
Series B in 2020
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
Nelumbo
Series A in 2020
Nelumbo Inc. is a materials innovation company based in Menlo Park, California, focused on developing advanced structural materials for the heating and cooling industry. Founded in 2015, the company specializes in manufacturing thin superomniphobic coatings, such as Ice-Nein and Omniphobe. These coatings enhance the performance of cooling coils in refrigeration and air conditioning systems by reducing frost buildup and improving energy efficiency, thereby minimizing equipment downtime and corrosion. Nelumbo's technology aims to unlock significant market opportunities by contributing to reductions in carbon emissions and energy consumption globally.
Tricog Health
Series B in 2020
Tricog Health specializes in developing advanced cardiac diagnostic tools aimed at addressing cardiovascular conditions with precision and timeliness. Utilizing medical-grade artificial intelligence, Tricog's solutions facilitate real-time reporting and analysis of electrocardiography results, enabling healthcare providers to identify cardiac issues quickly and accurately. The company focuses on bridging gaps in cardiac care infrastructure, expertise, and efficiency, ensuring that patients receive prompt diagnoses and timely interventions. Tricog is dedicated to enhancing cardiac care accessibility by providing virtual diagnostic tools and services, thereby supporting healthcare professionals in delivering reliable and consistent patient care.
OPALai
Seed Round in 2020
OPALai offers AI-driven digital financial products working on commodities and FX markets for pricing, hedging, and trading.
VividQ
Seed Round in 2019
VividQ Limited is a software company specializing in the development of a framework that enables the generation, compression, and transmission of 3D holographic images and video. The company offers several key products, including VividQ Capture, which standardizes 3D data for holographic display, and VividQ Squeeze, a compression solution for point cloud data storage. Additionally, VividQ Core facilitates multi-user interactions with holograms, while VividQ View allows developers to integrate various spatial light modulators into their systems. The company's technology is utilized across various sectors, including consumer electronics, augmented and virtual reality, automotive displays, and immersive simulations. Founded in 2015 and based in Cambridge, United Kingdom, VividQ collaborates with leading original equipment manufacturers to integrate its advanced software and hardware solutions into next-generation consumer devices, aiming to create a seamless blend of real and virtual experiences.
Goryo Chemical
Venture Round in 2019
Goryo Chemical, Inc. is a company based in Sapporo, Japan, with an additional office in Tokyo, that specializes in the development and sales of fluorescent probes and functional dyes for chemical biology and bio applications. Founded in 2010, the company offers a range of products and services, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and IndoCyanine green dye series, as well as bioluminescent probes and custom synthesis services. These probes are designed for cellular analysis, assay, and imaging, allowing for selective staining of acidic organelles like lysosomes and late endosomes, which can aid in medical diagnostics and treatment. Goryo Chemical serves a diverse customer base through a network of distributors both in Japan and internationally.
SWAT Mobility
Series A in 2019
SWAT Mobility specializes in vehicle-routing technology aimed at addressing complex transportation challenges faced by companies, transport operators, and government agencies globally. The company's innovative solutions utilize advanced artificial intelligence algorithms to optimize route planning and pooling, enhancing transport efficiency while accommodating multiple waypoints. By offering high-capacity vehicle pooling services that are both on-demand and dynamically routed, SWAT Mobility has demonstrated success in reducing transportation costs, improving urban connectivity, and alleviating traffic congestion. Their technology is designed to meet current logistics needs and is well-positioned for future advancements, including the integration of autonomous vehicles.
Algal Bio
Venture Round in 2019
Algal Bio Co., Ltd., established in 2018 and based in Kashiwa, Japan, specializes in the research, development, production, and sale of algae and its components. Drawing on two decades of research from the University of Tokyo, the company focuses on producing rare fatty acids and carotenoids while also engaging in food processing, importing, exporting, and distributing algae and its ingredients. Algal Bio operates a laboratory dedicated to exploring the functionality of microalgae as food ingredients, employing a unique algae bio-foundry platform that integrates various screening and cultivation technologies. The company aims to address significant global challenges, including rising health consciousness, food shortages, and climate change, by applying algae across diverse industries and applications.
Wassha
Series B in 2019
Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.
Retrieva
Venture Round in 2019
Retrieva, Inc. is a technology company based in Tokyo, Japan, specializing in the development of artificial intelligence-based software solutions for call centers. Founded in 2016, the company harnesses natural language processing and machine learning to create innovative products that enhance communication and operational efficiency. Its offerings include Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, which provides analytical insights. Retrieva's technology is designed to address enterprise customer challenges by delivering user-friendly services that improve inquiry analysis and response support in call center environments.
Adacotech
Venture Round in 2019
Adacotech specializes in the development of video surveillance systems and anomaly detection software aimed at enhancing manufacturing processes. The company creates in-house solutions that integrate advanced algorithms for real-time monitoring and detection of events, ensuring effective oversight around the clock. Its software is designed for various applications, including product inspection and monitoring of production equipment, as well as the assessment of social infrastructure. By utilizing inputs from images, videos, sounds, and sensors, Adacotech enables clients to perform primary screenings efficiently, thereby streamlining their operations and improving quality control.
Mujin
Venture Round in 2019
Mujin Inc. specializes in providing solutions for industrial robotics and factory automation, with a focus on enhancing productivity in manufacturing and logistics. Founded in 2011 and based in Tokyo, the company offers a range of products including the Mujin Controller Sim for programming industrial robots, Mujin Scanner for 3D modeling, Pick Worker for bin-picking with real-time motion planning, and Laser Worker for laser cutting applications. Mujin's intelligent robot controllers address common limitations faced by traditional robots, enabling better adaptability in dynamic environments. The company also provides comprehensive services such as robot system design, controller design, and motion planning, which are crucial for automating both heavy and repetitive tasks. With its advanced motion planning technology, Mujin aims to simplify factory automation and facilitate the integration of robots into complex real-time systems, ultimately streamlining operations that were previously reliant on human labor.
OriCiro Genomics
Series A in 2019
OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.
Startbahn
Series A in 2019
Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.
EditForce
Corporate Round in 2019
EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. The company specializes in genome editing alternatives and offers advanced tools for RNA molecule editing, utilizing pentatricopeptide repeat (PPR) protein engineering technologies. EditForce's innovations focus on manipulating nucleic acids, specifically DNA and RNA, to facilitate research and development in various fields, including biological research, medicine, agriculture, and bio-production. Their technology allows for precise targeting of base sequences in nucleic acids, enabling significant advancements in drug development and seed research.
estie
Seed Round in 2019
Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.
BionicM
Seed Round in 2019
BionicM is a Tokyo-based company focused on researching, developing, and commercializing advanced mobility devices that integrate robotics with the human body. Established as a joint-stock company in 2018, BionicM specializes in high-performance robotic prosthetics, including ankle-foot and knee joints, designed to enhance mobility for individuals with disabilities. The company has been engaged in innovative technology research since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, working under the guidance of Professor Inaba. BionicM's products aim to enable users, including both handicapped and non-handicapped individuals, to perform essential daily activities such as standing, walking, and climbing stairs.
PharmaBio
Venture Round in 2019
PharmaBio Corporation is a health care company based in Nagoya, Japan, specializing in the contract development and manufacturing of cellular and tissue-based products. Established in 1978, the company focuses on developing cell-based investigational new drugs and provides a range of services, including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a Good Manufacturing Practice (GMP)-compliant facility for the storage of cell-based drugs and test specimens. Additionally, the company offers strategic development consultation and research services to support the regulatory development of cell and tissue-based medicine. By emphasizing safety and quality, PharmaBio aims to enhance the production of improved-quality medical products derived from living cells and tissues, contributing to advancements in regenerative medicine.
bitBiome
Seed Round in 2019
bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms, employing single-cell technology to enhance enzyme discovery and engineering. The company boasts the largest proprietary database of natural microbial sequences, primarily sourced from environmental collections. Through its microbial single-cell sequencing platform, bit-MAP, it provides a variety of services, including single-cell genomics, database screening, and wet lab evaluation of target sequences. Additionally, bitBiome is dedicated to developing new diagnostics and drugs by analyzing bacteria that promote human health on a cell-by-cell basis.
Obniz
Seed Round in 2018
Obniz is a technology company that specializes in Internet of Things (IoT) services, offering a cloud-based system for real-time and bi-directional access to physical hardware. This platform enables users to remotely control various devices, including sensors, actuators, and machines, through the cloud. Obniz provides solutions for location information acquisition and environmental management, allowing clients to seamlessly connect their devices to the cloud and manage them effectively.
ImmunoScape
Seed Round in 2018
ImmunoScape is a company specializing in immunomics, focusing on immune profiling and the characterization of the human immune response with high precision. Its Deep Immunomics platform integrates advanced technologies such as mass cytometry, single cell sequencing, and proprietary computational bioinformatics to deliver detailed immune profiling information. This platform is particularly valuable in therapeutic areas like oncology and infectious diseases, where it aids in understanding the safety and efficacy of immunotherapies and in identifying potential drug targets. Additionally, ImmunoScape offers a software suite that includes immune cell profiling technologies and antigen-specific T-cell identification, providing crucial insights for companies involved in the research and clinical development of immunotherapies.
Socium
Venture Round in 2018
Socium Inc., based in Japan, is an AI-powered company specializing in drug discovery and development, focusing on first-in-class small molecules. The organization has a diverse development portfolio addressing over 23 diseases, including oncology and rare diseases. By employing an in-silico system bolstered by advanced algorithms, Socium streamlines the traditional drug discovery process, significantly reducing the time required to identify drug discovery targets to just a few months. The company utilizes a systems biology approach, leveraging augmented intelligence and machine learning to analyze comprehensive OMICS data rather than merely hypothesizing disease mechanisms. This methodology also allows for drug repositioning, enabling the healthcare industry to uncover new therapeutic uses for existing pharmaceuticals.
Locix
Series B in 2018
Locix, Inc. specializes in developing advanced technology products and services aimed at enhancing spatial and contextual awareness for smart homes and commercial environments. The company offers a range of solutions, including the Locix HD Vision sensor, which collects visual insights for monitoring and analysis, and the Locix Local Positioning System, which provides accurate indoor and outdoor location tracking for Wi-Fi enabled devices. Additional offerings include SmartDock, which utilizes AI to optimize loading and unloading processes, and SmartLPS, which digitizes and analyzes operational data in warehouses. Locix also provides solutions for monitoring various environments, such as warehouses and construction sites, as well as tools for contact tracing and compliance during the COVID-19 pandemic. Founded in 2015 and based in Silicon Valley, Locix has received backing from multiple venture and strategic investors.
Neural Pocket
Venture Round in 2018
Neural Pocket Inc. is a technology company based in Tokyo, Japan, that specializes in developing proprietary AI technologies focused on image and video analysis. Founded in 2018, the company offers a range of services aimed at creating smart cities, including solutions for mobility, facility and infrastructure management, and security through people and object movement tracking. Additionally, Neural Pocket provides digital signage services tailored for advertisers, developers, and commercial facilities. The firm also offers AI-driven fashion trend analysis, utilizing data from social networking and shopping sites to provide insights into fashion trends. Formerly known as Fashion Pocket Inc., the company rebranded in March 2019 to reflect its broader focus on AI applications beyond the fashion industry.
BUGWORKS Research
Series A in 2018
Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.
AI inside
Venture Round in 2018
AI Inside Inc. is a Tokyo-based company specializing in artificial intelligence and software development, particularly focusing on optical character recognition (OCR) services. Founded in 2015, AI Inside is dedicated to facilitating the digital transformation of society by converting various forms of information into digital data. The company offers an AI-powered platform known as the DX Suite, which aims to enhance productivity across different sectors. Through its innovative algorithms, AI Inside contributes to the advancement of a digital society by streamlining data processing and improving operational efficiency for its clients.
Nohla Therapeutics
Series B in 2018
Nohla Therapeutics, Inc. is focused on developing and manufacturing ex vivo expanded universal donor cellular therapies aimed at treating cancer and other life-threatening illnesses. The company utilizes a unique umbilical cord blood expansion platform to create and expand key cancer-fighting cells, enabling treatment without the need for HLA matching. Nohla's primary offerings include a Natural Killer (NK) cell program and a hematopoietic stem cell (HSC) expansion platform, which supports the clinical development of its flagship product, Dilanubicel. This off-the-shelf, ex vivo expanded hematopoietic stem and progenitor cell product is designed for immediate use to aid in hematopoietic recovery and address chemotherapy-induced neutropenia, among other indications. Founded in 2015 and based in Seattle, Washington, Nohla Therapeutics aims to streamline treatment processes while reducing patient risk and costs compared to traditional cell therapies.
Startbahn
Seed Round in 2018
Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.
Elixirgen Therapeutics
Series A in 2018
Elixirgen Therapeutics, a biotechnology company based in Baltimore, Maryland, focuses on developing innovative therapies using stem cell biology to address various health conditions. The company specializes in regenerative and rejuvenative medicine, leveraging its proprietary ZSCAN4 protein, which enhances the developmental potency of embryonic stem cells and reactivates early embryonic genes in induced pluripotent stem cells. Elixirgen Therapeutics aims to treat diseases related to telomere dysfunction, aging, and other chromosomal disorders. Utilizing advanced research facilities in the Science + Technology Park at Johns Hopkins, the company conducts extensive research and development to create therapeutics from protein-based cells, enhancing immunity and targeting drug-resistant pathogens. Founded in 2017, Elixirgen Therapeutics operates as a subsidiary of Elixirgen, LLC, which has been active since 2012.
Fressets
Corporate Round in 2018
Fressets, Inc develops cryptocurrency wallet systems for virtual currency exchanges. It engages in research and development of emerging technology of cryptocurrency and blockchain. The company was founded in 2017 and is headquartered in Tokyo, Japan.
Mirtel
Venture Round in 2018
MiRTeL is a healthcare technology company that specializes in providing innovative solutions for early disease detection and personalized healthcare. The company offers clinical and gene testing services aimed at enhancing health examinations. Its laboratory testing focuses on detecting exosomes and genetic disorders, which helps healthcare organizations improve patient longevity while reducing medical costs. By facilitating early detection of cancer and pre-illness conditions, MiRTeL contributes to more effective healthcare outcomes and supports research initiatives in the medical field.
Aidemy
Series A in 2018
Aidemy Inc. is a Tokyo-based company that offers online artificial intelligence programming services aimed at individuals and enterprises. Founded in 2014, it provides a comprehensive learning platform where users can acquire AI technology skills through practical applications. Aidemy's services include an all-in-one teaching environment and digital transformation support, facilitating the development of digital talent in organizations. Its solutions are particularly beneficial for corporations in the manufacturing sector, as well as smaller companies and academic institutions. Aidemy's offerings range from online learning resources to consulting services that assist businesses in implementing AI and digital transformation initiatives, ensuring effective human resource development and operational support.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.